Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Adverum Biotechnologies Inc (NASDAQ:ADVM) Director Mehdi Gasmi sold 10,000 shares of the company’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $21.86, fo

Editas Medicine (NASDAQ:EDIT) Trading Up 8.6%

05:50am, Saturday, 20'th Jun 2020
Editas Medicine Inc (NASDAQ:EDIT)’s share price rose 8.6% during mid-day trading on Thursday . The stock traded as high as $33.55 and last traded at $32.45, approximately 1,818,154 shares changed ha
Adverum Biotechnologies Inc (NASDAQ:ADVM) President Leone D. Patterson sold 13,171 shares of the firm’s stock in a transaction that occurred on Tuesday, June 16th. The stock was sold at an average p

Good News on Covid-19 Treatments

03:08pm, Friday, 19'th Jun 2020
A cheap pill for inflammation expands the list of proven drugs to three, and Gilead’s CEO is looking into inhaled remdesivir. How the medicines compare. Plus, what to make of day-trading Twitter cel
Editas Medicine Inc (NASDAQ:EDIT) – Stock analysts at SunTrust Banks issued their Q3 2020 earnings estimates for shares of Editas Medicine in a research note issued to investors on Thursday, June 18
Editas Medicine (NASDAQ:EDIT) was upgraded by stock analysts at BidaskClub from a “sell” rating to a “hold” rating in a research note issued to investors on Friday, BidAskClub reports. Several
There are still two ongoing studies of the drug in patients infected with the novel coronavirus.
Stocks Analysis by Zacks Investment Research covering: Exxon Mobil Corp, Natural Gas Futures, Cirrus Logic Inc, DSP Group Inc. Read Zacks Investment Research's latest article on Investing.com

A Stockpicker on the Reshaping of Health Care

08:12pm, Thursday, 18'th Jun 2020
Fidelity’s Eddie Yoon discusses the coronavirus pandemic, how we’ll get through it, and how it will further unleash forces changing the delivery, payment, and access to health care

Taking Winnebago Options for a Ride

10:00am, Thursday, 18'th Jun 2020
Winnebago is up more than 300% since mid-March. It reports earnings on June 24. Aggressive investors can consider a “bull spread” that pays off if the stock surges on earnings.
Adverum Biotechnologies (NASDAQ:ADVM) had its price objective increased by research analysts at Royal Bank of Canada from $24.00 to $30.00 in a research note issued on Tuesday, The Fly reports. The br
Editas Medicine Inc (NASDAQ:EDIT) was the target of unusually large options trading activity on Wednesday. Stock investors bought 3,252 call options on the stock. This is an increase of approximately
Human trials will start next month.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE